| Grant number: | 16/12039-7 |
| Support Opportunities: | Scholarships in Brazil - Master |
| Start date: | July 01, 2016 |
| End date: | April 30, 2018 |
| Field of knowledge: | Biological Sciences - Biochemistry - Metabolism and Bioenergetics |
| Principal Investigator: | Tatiana Rosado Rosenstock |
| Grantee: | Mariana Dutra Brito |
| Host Institution: | Faculdade de Ciências Médicas da Santa Casa de São Paulo (FCMSCSP). São Paulo , SP, Brazil |
| Associated research grant: | 15/02041-1 - The role of lysine(K)-deacetylases on mitochondrial disorders's neuroprotection: Perspectives of epigenetic therapy for Amyotrophic Lateral Sclerosis and Schizophrenia, AP.JP |
Abstract One of the major concerns related to neurodegenerative diseases is the development of neuroprotective strategies. Concerning to that, epigenetic modification is one of the most promising; in fact, lysine (K) acetylation is a highlighted topic. Because lysine(K)-deacetylases (KDACs) regulate proteins involved in mechanisms such as gene transcription, cellular clearance and metabolism, in which mitochondria plays an essential role, the aim of this project is to characterize the role of KDACs on mitochondrial function and degradation (mitophagy) in different models of Amyotrophic Lateral Sclerosis (ALS); it is known that mitochondria is related to the etiology and/or progression of this disorder. ALS is characterized by progressive motor neuron degeneration and, despite of the most cases of the disease are sporadic (90%), a small percentage is due to genetic factors (familial cases; FALS). From FALS, 15-20% of the cases are related to a mutation in the superoxide dismutase Cu/Zn (SOD1) gene, an antioxidant enzyme. However, ALS is still considered a multifactorial disorder since it presents not only changes in genic expression and increase in oxidative stress, but also excitotoxicity and mitochondrial dysfunction. To reach the goal proposed herein, neurons and/or astrocytes from hSOD1 G93A rats and immortalized cells, SH-SY5Y, in the presence or absence of mutated SOD1 will be used. Altogether, new therapeutic strategies could be developed targeting neuroprotection through augmentation of mitochondrial function and/or mitophagy. | |
| News published in Agência FAPESP Newsletter about the scholarship: | |
| More itemsLess items | |
| TITULO | |
| Articles published in other media outlets ( ): | |
| More itemsLess items | |
| VEICULO: TITULO (DATA) | |
| VEICULO: TITULO (DATA) | |